Gwen McMillin

Gwen McMillin, PhD, FACB

Gwen McMillin received a PhD in pharmacology, and is certified by the American Board of Clinical Chemistry in both Clinical Chemistry and Toxicological Chemistry. She is currently the Medical Director of Clinical Drug Abuse Testing and Trace Elements, as well as co-Medical Director of Pharmacogenomics, at ARUP Laboratories, in Salt Lake City, UT, and an Associate Professor (clinical) of Pathology at the University of Utah, School of Medicine. She is also the current Chair of AACC’s TDM/Toxicology Division.